@article{c275246deba448dbb52632c7c23af546,
title = "Comparison of four clinical risk scores in comatose patients after out-of-hospital cardiac arrest",
abstract = "Background and aims: Several different scoring systems for early risk stratification after out-of-hospital cardiac arrest have been developed, but few have been validated in large datasets. The aim of the present study was to compare the well-validated Out-of-hospital Cardiac Arrest (OHCA) and Cardiac Arrest Hospital Prognosis (CAHP)-scores to the less complex MIRACLE2- and Target Temperature Management (TTM)-scores. Methods: This was a post-hoc analysis of the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial. Missing data were handled by multiple imputation. The primary outcome was discriminatory performance assessed as the area under the receiver operating characteristics-curve (AUROC), with the outcome of interest being poor functional outcome or death (modified Rankin Scale 4–6) at 6 months after OHCA. Results: Data on functional outcome at 6 months were available for 1829 cases, which constituted the study population. The pooled AUROC for the MIRACLE2-score was 0.810 (95% CI 0.790–0.828), 0.835 (95% CI 0.816–0.852) for the TTM-score, 0.820 (95% CI 0.800–0.839) for the CAHP-score and 0.770 (95% CI 0.748–0.791) for the OHCA-score. At the cut-offs needed to achieve specificities >95%, sensitivities were <40% for all four scoring systems. Conclusions: The TTM-, MIRACLE2- and CAHP-scores are all capable of providing objective risk estimates accurate enough to be used as part of a holistic patient assessment after OHCA of a suspected cardiac origin. Due to its simplicity, the MIRACLE2-score could be a practical solution for both clinical application and risk stratification within trials.",
keywords = "Out-of-hospital cardiac arrest, Outcome, Outcome prediction, Risk prediction, Risk score",
author = "Simon Schmidbauer and Christian Rylander and Alain Cariou and Wise, {Matt P.} and Matthew Thomas and Keeble, {Thomas R.} and David Erlinge and Matthias Haenggi and Wendel-Garcia, {Pedro D.} and Jan B{\v e}lohl{\'a}vek and Grejs, {Anders Morten} and Niklas Nielsen and Hans Friberg and Josef Dankiewicz",
note = "Funding Information: The TTM2-trial was supported by independent research grants from nonprofit or governmental agencies (the Swedish Research Council [Vetenskapsr{\aa}det], Swedish Heart–Lung Foundation, Stig and Ragna Gorthon Foundation, Knutsson Foundation, Laerdal Foundation, Hans-Gabriel and Alice Trolle-Wachtmeister foundation for medical Research, and regional research Support in Region Sk{\aa}ne) and by governmental funding of clinical research within the Swedish National Health Service. Authors S.S and H.F received regional research support from Region Sk{\aa}ne and funding from the Laerdal Foundation, respectively, for the present work. Funding Information: The TTM2-trial was supported by independent research grants from nonprofit or governmental agencies (the Swedish Research Council [Vetenskapsr{\aa}det], Swedish Heart–Lung Foundation , Stig and Ragna Gorthon Foundation , Knutsson Foundation , Laerdal Foundation , Hans-Gabriel and Alice Trolle-Wachtmeister foundation for medical Research , and regional research Support in Region Sk{\aa}ne ) and by governmental funding of clinical research within the Swedish National Health Service. Authors S.S and H.F received regional research support from Region Sk{\aa}ne and funding from the Laerdal Foundation, respectively, for the present work. Publisher Copyright: {\textcopyright} 2023 The Author(s)",
year = "2023",
month = oct,
doi = "10.1016/j.resuscitation.2023.109949",
language = "English",
volume = "191",
journal = "Resuscitation",
issn = "0300-9572",
publisher = "Elsevier",
}